MiniMed Group, Inc. Common Stock
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- MiniMed Group, Inc. (MMED) is a medical technology company focused on diabetes management solutions. The company develops, manufactures, and markets advanced insulin pumps, continuous glucose monitoring (CGM) systems, and related diabetes care products, including the MiniMed Paradigm insulin pump system; the Guardian CGM sensors and transmitters; integrated sensor-augmented pump therapy; and software platforms for data analysis and remote monitoring. It serves patients, healthcare providers, and distributors primarily in North America, Europe, and select Asia-Pacific markets. Founded in 1983 and headquartered in Northridge, California, MiniMed pioneered external insulin infusion pumps and expanded into sensor technology through key innovations in the 1990s and 2000s. In recent years, the company has pursued strategic growth, including a 2024 partnership with a leading digital health platform to enhance app-based diabetes management integration and a 2025 Series B funding round exceeding $150 million to accelerate next-generation CGM development. Additionally, MiniMed launched its MiniMed 870G system with automated insulin delivery in late 2025, marking a significant advancement in closed-loop therapy, while expanding operations into Latin America through a new distribution alliance.
Company News
Why MiniMed Stock Was Soaring This Week
MiniMed Group: Recurring Revenues And Fresh Product Cycle
Deutsche Bank AG Invests $420,000 in MiniMed Group Inc $MMED
These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results
MiniMed Group, Inc. (MMED) Q1 2027 Earnings Call Transcript
MiniMed Group Q1 Earnings Call Highlights
MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
Top Wall Street Forecasters Revamp MiniMed Group Expectations Ahead Of Q1 Earnings
MiniMed to Participate in Upcoming Investor Conferences
MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor
MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor
This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run
MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access
MiniMed: Next-Generation Diabetes Platform Supports A Buy Rating
MiniMed Flex™ Now Available to Medicare and Medicare Advantage Beneficiaries
MiniMed to Announce Its Fiscal Year 2027 First Quarter Financial Results
MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors
MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors
MiniMed Launches Abbott's Instinct Sensors Across European Markets
MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes